Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-01-05 Sale |
2021-01-05 8:58 pm |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
1,377 | $55.86 | $76,919 | 31,031 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-03-03 Option Award |
2021-03-05 5:53 pm |
N/A 2031-03-02 |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
91,875 | $0 | 91,875 (Direct) |
View |
2020-12-31 Option Award |
2021-01-05 8:58 pm |
2020-12-31 2028-03-20 |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
14,375 | $0 | 31,031 (Direct) |
View |
2020-12-31 Exercise |
2021-01-05 8:58 pm |
2020-12-31 N/A |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
4,792 | $0 | 31,031 (Direct) |
View |
2020-12-30 Exercise |
2021-01-04 9:03 pm |
N/A 2027-01-02 |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
1,500 | $0 | 161,173 (Direct) |
View |
2020-12-30 Exercise |
2021-01-04 9:03 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
1,500 | $13.48 | 161,173 (Direct) |
View |